← All candidates
27 insider filings on record.
27 filings on record.
LFCRLIFECORE BIOMEDICAL, INC. \DE\
NasdaqGS · Healthcare · $165.79M
$4.42
27 insider filings on record.
None of them an open-market buy in the last year.
No price data yet — the yfinance scanner hasn't produced bars for LFCR.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$165.79M
Float
19.4M
52% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
1.3
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
22 more transactions on Pro →Context
Wall St
$6.75 avg target
+52.7% vs today · 3 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Coverage
Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess CapacityInsider Monkey · 4w agoLifecore Biomedical (LFCR) Q2 2026 Earnings Call TranscriptMotley Fool · 08-12Lifecore Biomedical, Inc. Q2 2026 Earnings Call SummaryMoby · 08-06Lifecore Biomedical Inc (LFCR) (Q2 2026) Earnings Call Highlights: Strategic Wins and Capacity ...GuruFocus.com · 08-05
The file stays open
27 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice